PFIZER INC - 17 Mar 2023 Form 4/A - Amendment Insider Report for Pyxis Oncology, Inc. (PYXS)

Reporting relationship: 10%+ Owner
Issuer ticker: PYXS
Reported as of: 17 Mar 2023
Net transaction value: +$4,999,999
SEC form: 4/A - Amendment
Accepted by SEC: 23 Mar 2023, 16:14:26 UTC
Original report date: 21 Mar 2023
Prior SEC filing: 29 Dec 2022
Next SEC filing: 30 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Susan Grant, Assistant Secretary

Key filing fact

PFIZER INC filed Form 4/A - Amendment for Pyxis Oncology, Inc. (PYXS) on 23 Mar 2023.

Key facts

This page summarizes PFIZER INC's Form 4/A - Amendment filing for Pyxis Oncology, Inc. (PYXS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Mar 2023, 16:14.

Change

Previous filing in this sequence was filed on 29 Dec 2022.
Current net transaction value: +$4,999,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PYXS transaction

Common Stock, $0.001 par value per share

Purchase

Transaction value: $4,999,999
Shares: +1,811,594
Change %: +44%
Price: $2.76
Shares after: 5,952,263
Date: 17 Mar 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The securities were issued under that certain first amendment dated March 16, 2023 to the Amended and Restated License Agreement dated October 14, 2022 between the Reporting Person and the Issuer, pursuant to which the Issuer agreed to issue to the Reporting Person such number of shares of common stock equivalent to $5.0 million at a per share price equal to the closing price of the Issuer's common stock on the business day when the closing price of the Issuer's common stock on the Nasdaq Global Select Market is at or above $2.46 per share on any day between March 16, 2023 and a date that is within 180 days following October 6, 2022.

Footnote F2

On March 17, 2023, the closing price of the Issuer's common stock on the Nasdaq Global Select Market was $2.76 per share.

SEC remarks

The only amendments made to the previously filed Form 4 are to add footnotes (1) and (2) in column (4).